source
- FDA sends warning letters to Sanofi and Viatris over misleading product claimsThe FDA’s Office of Prescription Drug Promotion issued untitled warning letters to Sanofi and Viatris after reviewing promotional materials that the agency deemed misleading. The letters cite spec…
- Study finds Merck’s Ervebo may protect against Bundibugyo Ebola strain, prompting calls for DRC testingNew data from a human study published in the New England Journal of Medicine suggests Merck's Ervebo vaccine, licensed for the Zaire ebolavirus, may also offer protection against the Bundibugyo spe…